We are live on ! Find out more
CF

Crosspoint Financial Portfolio holdings

AUM $39.8M
1-Year Est. Return 14.13%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+14.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.83M
AUM Growth
+$543K
Cap. Flow
+$63K
Cap. Flow %
0.64%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
1
Closed

Top Sells

Rank Stock Value
1
UFOX
Defiance Space and Connective Tech ETF
UFOX
+$26.6K

Sector Composition

Rank Sector Weight
1 Financials 29.85%
2 Communication Services 3.17%
3 Healthcare 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.93M 29.85%
8,605
UFOX
2
Defiance Space and Connective Tech ETF
UFOX
$862M
$2.31M 23.49%
68,581
-840
-1% -$26.6K
OIH icon
3
VanEck Oil Services ETF
OIH
$2.05B
$1.32M 13.43%
4,589
IHAK icon
4
iShares Cybersecurity and Tech ETF
IHAK
$1.01B
$1.29M 13.1%
34,035
+1
+0% +$36
XJUN icon
5
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$140M
$771K 7.84%
23,050
IAU icon
6
iShares Gold Trust
IAU
$62.4B
$729K 7.42%
20,042
META icon
7
Meta Platforms (Facebook)
META
$1.64T
$311K 3.17%
1,085
+100
+10% +$24.7K
TERN
8
DELISTED
Terns Pharmaceuticals
TERN
$105K 1.07%
12,054
ALLO icon
9
Allogene Therapeutics
ALLO
$618M
$59.6K 0.61%
+12,000
New +$64.9K
MVSTW icon
10
Microvast Holdings Warrants
MVSTW
$421K
$2.05K 0.02%
10,000

Similar funds

Crosspoint Financial's Q2 2023 Portfolio in Review

As of Q2 2023, Crosspoint Financial held 10 positions worth $9.83M, up 5.9% from $9.29M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Crosspoint Financial's Q2 2023 filing shows 1 new, 2 increased and 1 reduced positions. Its largest new stake was Allogene Therapeutics: 12,000 shares worth $59.6K. The largest sale was Defiance Space and Connective Tech ETF, an estimated $26.6K.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Communication Services and Healthcare.

  • Crosspoint Financial's largest Q2 2023 buy was Allogene Therapeutics: 12,000 shares worth $59.6K.
  • Crosspoint Financial added most to Meta Platforms (Facebook) in Q2 2023, an estimated $24.7K increase.
  • Crosspoint Financial's biggest Q2 2023 reduction was Defiance Space and Connective Tech ETF, cutting an estimated $26.6K.
  • Crosspoint Financial's ten largest holdings make up 100% of its $9.83M portfolio in Q2 2023.
  • Crosspoint Financial opened 1 new position and closed 0 in Q2 2023.
  • Crosspoint Financial's portfolio value rose 5.9% quarter-over-quarter to $9.83M.

Based on Crosspoint Financial's 13F filing for Q2 2023, filed 10 Aug 2023.